Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor

In March 2020, the World Health Organization (WHO) declared COVID-19 a pandemic, and the spike protein has been reported to be an important drug target for anti-COVID-19 treatment. As such, in this study, we successfully developed a novel electrochemical receptor biosensor by immobilizing the SARS-C...

Full description

Bibliographic Details
Main Authors: Dingqiang Lu, Danyang Liu, Xinqian Wang, Yujiao Liu, Yixuan Liu, Ruijuan Ren, Guangchang Pang
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/12/10/888
_version_ 1797474787336912896
author Dingqiang Lu
Danyang Liu
Xinqian Wang
Yujiao Liu
Yixuan Liu
Ruijuan Ren
Guangchang Pang
author_facet Dingqiang Lu
Danyang Liu
Xinqian Wang
Yujiao Liu
Yixuan Liu
Ruijuan Ren
Guangchang Pang
author_sort Dingqiang Lu
collection DOAJ
description In March 2020, the World Health Organization (WHO) declared COVID-19 a pandemic, and the spike protein has been reported to be an important drug target for anti-COVID-19 treatment. As such, in this study, we successfully developed a novel electrochemical receptor biosensor by immobilizing the SARS-CoV-2 spike protein and using AuNPs-HRP as an electrochemical signal amplification system. Moreover, the time-current method was used to quantify seven antiviral drug compounds, such as arbidol and chloroquine diphosphate. The results show that the spike protein and the drugs are linearly correlated within a certain concentration range and that the detection sensitivity of the sensor is extremely high. In the low concentration range of linear response, the kinetics of receptor–ligand interactions are similar to that of an enzymatic reaction. Among the investigated drug molecules, bromhexine exhibits the smallest Ka value, and thus, is most sensitively detected by the sensor. Hydroxychloroquine exhibits the largest Ka value. Molecular docking simulations of the spike protein with six small-molecule drugs show that residues of this protein, such as Asp, Trp, Asn, and Gln, form hydrogen bonds with the -OH or -NH<sub>2</sub> groups on the branched chains of small-molecule drugs. The electrochemical receptor biosensor can directly quantify the interaction between the spike protein and drugs such as abidor and hydroxychloroquine and perform kinetic studies with a limit of detection 3.3 × 10<sup>−</sup><sup>20</sup> mol/L, which provides a new research method and idea for receptor–ligand interactions and pharmacodynamic evaluation.
first_indexed 2024-03-09T20:36:03Z
format Article
id doaj.art-7d3d7b6747a045ec915255ef5c136497
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-09T20:36:03Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-7d3d7b6747a045ec915255ef5c1364972023-11-23T23:12:16ZengMDPI AGBiosensors2079-63742022-10-01121088810.3390/bios12100888Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor SensorDingqiang Lu0Danyang Liu1Xinqian Wang2Yujiao Liu3Yixuan Liu4Ruijuan Ren5Guangchang Pang6College of Biotechnology & Food Science, Tianjin University of Commerce, Tianjin 300134, ChinaCollege of Biotechnology & Food Science, Tianjin University of Commerce, Tianjin 300134, ChinaCollege of Biotechnology & Food Science, Tianjin University of Commerce, Tianjin 300134, ChinaCollege of Biotechnology & Food Science, Tianjin University of Commerce, Tianjin 300134, ChinaCollege of Biotechnology & Food Science, Tianjin University of Commerce, Tianjin 300134, ChinaTianjin Institute for Food Safety Inspection Technology, Tianjin 300134, ChinaCollege of Biotechnology & Food Science, Tianjin University of Commerce, Tianjin 300134, ChinaIn March 2020, the World Health Organization (WHO) declared COVID-19 a pandemic, and the spike protein has been reported to be an important drug target for anti-COVID-19 treatment. As such, in this study, we successfully developed a novel electrochemical receptor biosensor by immobilizing the SARS-CoV-2 spike protein and using AuNPs-HRP as an electrochemical signal amplification system. Moreover, the time-current method was used to quantify seven antiviral drug compounds, such as arbidol and chloroquine diphosphate. The results show that the spike protein and the drugs are linearly correlated within a certain concentration range and that the detection sensitivity of the sensor is extremely high. In the low concentration range of linear response, the kinetics of receptor–ligand interactions are similar to that of an enzymatic reaction. Among the investigated drug molecules, bromhexine exhibits the smallest Ka value, and thus, is most sensitively detected by the sensor. Hydroxychloroquine exhibits the largest Ka value. Molecular docking simulations of the spike protein with six small-molecule drugs show that residues of this protein, such as Asp, Trp, Asn, and Gln, form hydrogen bonds with the -OH or -NH<sub>2</sub> groups on the branched chains of small-molecule drugs. The electrochemical receptor biosensor can directly quantify the interaction between the spike protein and drugs such as abidor and hydroxychloroquine and perform kinetic studies with a limit of detection 3.3 × 10<sup>−</sup><sup>20</sup> mol/L, which provides a new research method and idea for receptor–ligand interactions and pharmacodynamic evaluation.https://www.mdpi.com/2079-6374/12/10/888SARS-CoV-2spike proteinelectrochemical receptor biosensorlinkage allosterism
spellingShingle Dingqiang Lu
Danyang Liu
Xinqian Wang
Yujiao Liu
Yixuan Liu
Ruijuan Ren
Guangchang Pang
Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor
Biosensors
SARS-CoV-2
spike protein
electrochemical receptor biosensor
linkage allosterism
title Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor
title_full Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor
title_fullStr Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor
title_full_unstemmed Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor
title_short Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor
title_sort kinetics of drug molecule interactions with a newly developed nano gold modified spike protein electrochemical receptor sensor
topic SARS-CoV-2
spike protein
electrochemical receptor biosensor
linkage allosterism
url https://www.mdpi.com/2079-6374/12/10/888
work_keys_str_mv AT dingqianglu kineticsofdrugmoleculeinteractionswithanewlydevelopednanogoldmodifiedspikeproteinelectrochemicalreceptorsensor
AT danyangliu kineticsofdrugmoleculeinteractionswithanewlydevelopednanogoldmodifiedspikeproteinelectrochemicalreceptorsensor
AT xinqianwang kineticsofdrugmoleculeinteractionswithanewlydevelopednanogoldmodifiedspikeproteinelectrochemicalreceptorsensor
AT yujiaoliu kineticsofdrugmoleculeinteractionswithanewlydevelopednanogoldmodifiedspikeproteinelectrochemicalreceptorsensor
AT yixuanliu kineticsofdrugmoleculeinteractionswithanewlydevelopednanogoldmodifiedspikeproteinelectrochemicalreceptorsensor
AT ruijuanren kineticsofdrugmoleculeinteractionswithanewlydevelopednanogoldmodifiedspikeproteinelectrochemicalreceptorsensor
AT guangchangpang kineticsofdrugmoleculeinteractionswithanewlydevelopednanogoldmodifiedspikeproteinelectrochemicalreceptorsensor